| scholarly article | Q13442814 |
| P2093 | author name string | Kirsten Axelsen | |
| Tami L Mark | |||
| Teresa B Gibson | |||
| Onur Baser | |||
| Kimberly A McGuigan | |||
| Dale A Rublee | |||
| P304 | page(s) | SP11-9 | |
| P577 | publication date | 2006-12-01 | |
| P1433 | published in | American Journal of Managed Care | Q15807020 |
| P1476 | title | Impact of statin copayments on adherence and medical care utilization and expenditures | |
| P478 | volume | 12 Spec no. |
| Q35913842 | A Welfare Measure of "Offset Effects" in Health Insurance |
| Q34036014 | A retrospective cohort study of the potency of lipid-lowering therapy and race-gender differences in LDL cholesterol control |
| Q28540727 | A systematic review of cost-sharing strategies used within publicly-funded drug plans in member countries of the organisation for economic co-operation and development |
| Q59813216 | Access and adherence to medications for the primary and secondary prevention of atherosclerotic cardiovascular disease in Singapore: a qualitative study |
| Q44003644 | Adherence to preventive statin therapy according to socioeconomic position |
| Q64967921 | Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in Kyrgyzstan. |
| Q34772182 | Association of Medicare Part D low-income cost subsidy program enrollment with increased fill adherence to clopidogrel after coronary stent placement |
| Q37050954 | Association of Medicare Part D medication out-of-pocket costs with utilization of statin medications |
| Q36503503 | Cardiovascular disease guideline adherence and self-reported statin use in longstanding type 1 diabetes: results from the Canadian study of longevity in diabetes cohort |
| Q64119575 | Does Public Health Insurance Coverage Lead to Better Health Outcomes? Evidence From Chinese Adults |
| Q58703615 | Effect of Medication Copayment on Adherence and Discontinuation in Medicare Beneficiaries with Type 2 Diabetes: A Retrospective Administrative Claims Database Analysis |
| Q41481474 | Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome. |
| Q33931921 | Estimates of commercial population at high risk for cardiovascular events: impact of aggressive cholesterol reduction |
| Q35962302 | Full coverage for hypertension drugs in rural communities in China. |
| Q35752951 | How patient cost-sharing trends affect adherence and outcomes: a literature review. |
| Q37365655 | Impact of a prescription copayment increase on lipid-lowering medication adherence in veterans. |
| Q46232603 | Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization |
| Q36666594 | Implementation of the Medicare Part D prescription drug benefit is associated with antiretroviral therapy interruptions |
| Q39455827 | Medication Nonadherence: The Role of Cost, Community, and Individual Factors |
| Q34509195 | Nonlinear pricing in drug benefits and medication use: the case of statin compliance in Medicare Part D. |
| Q34030812 | Patients' Perspectives on Nonadherence to Statin Therapy: A Focus-Group Study |
| Q37938836 | Predictors of statin adherence |
| Q34246573 | Predictors of statin compliance after switching from branded to generic agents among managed-care beneficiaries |
| Q36869615 | Prescription drug cost sharing: associations with medication and medical utilization and spending and health. |
| Q37119248 | Recognizing and improving patient nonadherence to statin therapy |
| Q33412577 | Systematic review on quality control for drug management programs: is quality reported in the literature? |
| Q35083824 | The impact of regional co-payment and national reimbursement criteria on statins use in Italy: an interrupted time-series analysis. |
| Q36741319 | The use of linear instrumental variables methods in health services research and health economics: a cautionary note |
| Q46841264 | Therapy compliance in cases of hyperlipaemia, as measured through electronic monitors. Is a reminder calendar to avoid forgetfulness effective? |
| Q36807244 | Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling |
| Q38269606 | When compliance is an issue-how to enhance statin adherence and address adverse effects |
Search more.